Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Biogen

BIIB

----

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors
MarketWatch Automated·1 day ago, 03:57 PM
BIIB+0.78%
KBC Group NV Raises Stock Position in Biogen Inc. $BIIB
Market Beat·Jul 21 at 04:29 AM
BIIB+0.78%
Biogen Inc. Stock Underperforms Monday When Compared To Competitors
MarketWatch Automated·Jul 20 at 03:58 PM
BIIB+0.78%
Bank of New York Mellon Corp Lowers Stock Position in Biogen Inc. $BIIB
Market Beat·Jul 20 at 02:13 AM
BIIB+0.78%BNY-0.75%
Biogen Inc. Stock Underperforms Friday When Compared To Competitors
MarketWatch Automated·Jul 17 at 03:57 PM
BIIB+0.78%
Illinois Municipal Retirement Fund Grows Stock Holdings in Biogen Inc. $BIIB
Market Beat·Jul 16 at 04:52 AM
BIIB+0.78%
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide | BIIB Stock News
StockTitan·Jul 15 at 10:47 PM
BIIB+0.78%
Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
MarketWatch Automated·Jul 15 at 03:58 PM
BIIB+0.78%
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Japan Corporate News·Jul 15 at 01:50 PM
4523 BIIB+0.78%
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Japan Corporate News·Jul 15 at 12:28 PM
4523 BIIB+0.78%
Why IBM Slumped, Nebius and Biogen Declined
Baystreet·Jul 15 at 08:55 AM
BIIB+0.78%NBIS-15.02%
Biogen Appoints Michael J. Parini as Chief Legal Officer | BIIB Stock News
StockTitan·Jul 14 at 11:15 PM
BIIB+0.78%